| Year |
Citation |
Score |
| 2023 |
Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, ... ... Leach RJ, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. PMID 37945903 DOI: 10.1038/s41588-023-01534-4 |
0.328 |
|
| 2023 |
Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, Wang A, Shen J, Saunders EJ, Rhie SK, Bensen JT, Ingles SA, Kittles RA, Strom SS, Rybicki BA, ... ... Leach R, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology. PMID 36872133 DOI: 10.1016/j.eururo.2023.01.022 |
0.341 |
|
| 2023 |
Lee J, Wickes BL, Fu J, Brockman NE, Garg H, Jobin C, Johson-Pais T, Leach R, Lai Z, Liss MA. Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer. The Prostate. PMID 36842100 DOI: 10.1002/pros.24500 |
0.324 |
|
| 2022 |
Ramamurthy C, Stutz EW, Goros M, Gelfond J, Johnson-Pais TL, Thompson IM, Leach RJ, Liss MA. Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer. Clinical Genitourinary Cancer. PMID 35260348 DOI: 10.1016/j.clgc.2022.01.008 |
0.327 |
|
| 2022 |
Huynh-Le MP, Karunamuni R, Fan CC, Asona L, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir KR, Lophatananon A, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, ... ... Leach RJ, et al. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Prostate Cancer and Prostatic Diseases. PMID 35152271 DOI: 10.1038/s41391-022-00497-7 |
0.34 |
|
| 2022 |
Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, Sheng X, Xia L, Andrews C, Chen F, Berndt SI, Kote-Jarai Z, Govindasami K, Bensen JT, Ingles SA, ... ... Leach RJ, et al. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European Urology. PMID 35031163 DOI: 10.1016/j.eururo.2021.12.023 |
0.346 |
|
| 2021 |
Clements MB, Vertosick EA, Guerrios-Rivera L, De Hoedt AM, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Haese A, Montorsi F, Boorjian SA, Poyet C, Ankerst DP, Vickers AJ. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort. European Urology. PMID 34980493 DOI: 10.1016/j.eururo.2021.12.011 |
0.326 |
|
| 2021 |
Huynh-Le MP, Fan CC, Karunamuni R, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir K, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Donovan JL, Hamdy FC, ... ... Leach RJ, et al. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. Nature Communications. 12: 1236. PMID 33623038 DOI: 10.1038/s41467-021-21287-0 |
0.311 |
|
| 2021 |
Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Leach RJ, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33398198 DOI: 10.1038/s41588-020-00748-0 |
0.319 |
|
| 2020 |
Liss MA, Leach RJ, Sanda MG, Semmes OJ. Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33093161 DOI: 10.1158/1055-9965.EPI-20-1104 |
0.327 |
|
| 2020 |
Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, Tangen CM, Goodman PJ, Thompson IM, Blot WJ, Zheng W, Kibel AS, ... ... Leach RJ, et al. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. International Journal of Cancer. PMID 32930425 DOI: 10.1002/Ijc.33282 |
0.395 |
|
| 2020 |
Ashcraft KA, Johnson-Pais TL, Troyer DA, Hernandez J, Leach RJ. A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome. Urologic Oncology. PMID 32665124 DOI: 10.1016/J.Urolonc.2020.06.015 |
0.439 |
|
| 2020 |
Otto JJ, Correll VL, Engstroem HA, Hitefield NL, Main BP, Albracht B, Johnson-Pais T, Yang LF, Liss M, Boutros PC, Kislinger T, Leach RJ, Semmes OJ, Nyalwidhe JO. Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination. Proteomics. Clinical Applications. e2000012. PMID 32614141 DOI: 10.1002/Prca.202000012 |
0.391 |
|
| 2020 |
Darst BF, Wan P, Sheng X, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Strom SS, Park JY, Zheng W, ... ... Leach R, et al. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. European Urology. PMID 32409115 DOI: 10.1016/J.Eururo.2020.04.060 |
0.413 |
|
| 2020 |
Drake RR, David F, Miller C, Jefferson M, Spruill L, Liss M, Weaver B, Angel PM, Leach R, Hughes-Halbert C. Abstract C032: Distinguishing lethal from indolent prostate cancer using N-glycan imaging mass spectrometry in a racial tissue microarray cohort Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C032 |
0.359 |
|
| 2020 |
Darst BF, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Park JY, Zheng W, Ostrander EA, Srivastava S, Carpten J, ... ... Leach R, et al. Abstract 3517: A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-3517 |
0.43 |
|
| 2020 |
Wheeler A, Furman J, Besasie B, Johnson-Pais T, Leach R, Liss M. Mp79-12 Microbiome Of Metastatic Prostate Cancer Lymph Nodes The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000971.012 |
0.351 |
|
| 2019 |
Tolksdorf J, Kattan MW, Boorjian SA, Freedland SJ, Saba K, Poyet C, Guerrios L, De Hoedt A, Liss MA, Leach RJ, Hernandez J, Vertosick E, Vickers AJ, Ankerst DP. Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools. Bmc Medical Research Methodology. 19: 191. PMID 31615451 DOI: 10.1186/S12874-019-0839-0 |
0.398 |
|
| 2019 |
Du Z, Hopp H, Ingles SA, Huff C, Sheng X, Weaver B, Stern M, Hoffmann TJ, John EM, Van Den Eeden SK, Strom S, Leach RJ, Thompson IM, Witte JS, Conti DV, et al. A Genome-wide Association Study of Prostate Cancer in Latinos. International Journal of Cancer. PMID 31226226 DOI: 10.1002/Ijc.32525 |
0.366 |
|
| 2019 |
Sharp AM, Lertphinyowong S, Yee SS, Paredes D, Gelfond J, Johnson-Pais TL, Leach RJ, Liss M, Risinger AL, Sullivan AC, Thompson IM, Morilak DA. Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. Psychopharmacology. PMID 31139875 DOI: 10.1007/S00213-019-05274-4 |
0.374 |
|
| 2019 |
Liss MA, Leach RJ, Rourke E, Sherrill A, Johnson-Pais T, Lai Z, Basler J, White JR, Patterson JE. Microbiome diversity in carriers of fluoroquinolone resistant . Investigative and Clinical Urology. 60: 75-83. PMID 30838339 DOI: 10.4111/Icu.2019.60.2.75 |
0.305 |
|
| 2019 |
Liss M, Stutz E, Johnson-Pais T, Thompson I, Leach R. Pd60-08 Brca Mutations In Hispanic Men With First Degree Prostate And Breast Cancer History The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557268.51342.6E |
0.399 |
|
| 2018 |
Liss MA, Al-Bayati O, Gelfond J, Goros M, Ullevig S, DiGiovanni J, Hamilton-Reeves J, O'Keefe D, Bacich D, Weaver B, Leach R, Thompson IM. Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study. Prostate Cancer and Prostatic Diseases. PMID 30385837 DOI: 10.1038/S41391-018-0105-2 |
0.387 |
|
| 2018 |
Hernandez J, Gelfond J, Goros M, Liss MA, Liang Y, Ankerst D, Thompson IM, Leach RJ. The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial. Plos One. 13: e0204823. PMID 30300367 DOI: 10.1371/Journal.Pone.0204823 |
0.355 |
|
| 2018 |
Liss MA, White JR, Goros M, Gelfond J, Leach R, Johnson-Pais T, Zhao L, Rourke E, Basler J, Ankerst D, Shah DP. Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer. European Urology. PMID 30007819 DOI: 10.1016/J.Eururo.2018.06.033 |
0.417 |
|
| 2018 |
Hariharan N, Ashcraft KA, Svatek RS, Livi CB, Wilson D, Kaushik D, Leach RJ, Johnson-Pais TL. Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration. Journal of Obesity. 2018: 9247864. PMID 29887999 DOI: 10.1155/2018/9247864 |
0.315 |
|
| 2018 |
Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, et al. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. European Urology. PMID 29778349 DOI: 10.1016/J.Eururo.2018.05.003 |
0.422 |
|
| 2018 |
Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, et al. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 9: 6550-6561. PMID 29464091 DOI: 10.18632/Oncotarget.23973 |
0.393 |
|
| 2018 |
Ankerst DP, Goros M, Tomlins SA, Patil D, Feng Z, Wei JT, Sanda MG, Gelfond J, Thompson IM, Leach RJ, Liss MA. Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. European Urology Focus. PMID 29422418 DOI: 10.1016/J.Euf.2018.01.010 |
0.413 |
|
| 2018 |
Chu LW, Till C, Yang B, Tangen CM, Goodman PJ, Yu K, Zhu Y, Han S, Hoque AM, Ambrosone C, Thompson I, Leach R, Hsing AW. Circadian Genes and Risk of Prostate Cancer in the Prostate Cancer Prevention Trial. Molecular Carcinogenesis. PMID 29318656 DOI: 10.1002/Mc.22770 |
0.437 |
|
| 2018 |
Liss M, Shah D, Leach R, Rourke E, Basler J, White J. Mp82-16 Intestinal Microbiome Analysis Identifies Bacteria And Biosynthesis Pathways Associated With Prostate Cancer The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2744 |
0.409 |
|
| 2018 |
Wendel E, Patil D, Weaver B, Leach R, Thompson I, Sokoll L, Chan D, Groskopf J, Carter J, Torlak M, Sanda M. Mp35-06 Multi-Center Prospective Study Of Prostate Health Index (Phi) Testing As A Strategy For Prostate Cancer Screening: Collaboration Between Urology, Primary Care, And Community Outreach The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1119 |
0.387 |
|
| 2017 |
Shi T, Quek SI, Gao Y, Nicora CD, Nie S, Fillmore TL, Liu T, Rodland KD, Smith RD, Leach RJ, Thompson IM, Vitello EA, Ellis WJ, Liu AY, Qian WJ. Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins. Oncotarget. 8: 101887-101898. PMID 29254211 DOI: 10.18632/Oncotarget.21710 |
0.434 |
|
| 2017 |
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng SL, Thompson IM, Lucia MS, Lippman SM, Parnes HL, Isaacs WB, De Marzo AM, et al. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. The Prostate. PMID 28317149 DOI: 10.1002/Pros.23346 |
0.408 |
|
| 2017 |
Wang H, Gao Y, Schepmoes A, Petrovics G, Cullen J, Fillmore T, Shi T, Qian W, Smith R, Weaver B, Leach R, Thompson I, Srivastava S, Kagan J, Dobi A, et al. Abstract 226: Verification of prostate cancer genomics biomarker candidates at protein level using PRISM-SRM Cancer Research. 77: 226-226. DOI: 10.1158/1538-7445.Am2017-226 |
0.401 |
|
| 2016 |
Chen H, Liu X, Brendler CB, Ankerst DP, Leach RJ, Goodman PJ, Lucia MS, Tangen CM, Wang L, Hsu FC, Sun J, Kader AK, Isaacs WB, Helfand BT, Zheng SL, et al. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial. The Prostate. PMID 27197965 DOI: 10.1002/Pros.23200 |
0.418 |
|
| 2016 |
Price DK, Chau CH, Till C, Goodman PJ, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Parnes HL, Schenk JM, Tangen CM, Thompson IM, Reichardt JK, Figg WD. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer. PMID 27164191 DOI: 10.1002/Cncr.30071 |
0.451 |
|
| 2016 |
Ankerst DP, Gelfond J, Goros M, Herrera J, Strobl A, Thompson IM, Hernandez J, Leach RJ. Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer. The Journal of Urology. PMID 26979652 DOI: 10.1016/J.Juro.2016.03.011 |
0.407 |
|
| 2016 |
Wang Y, Jadhav RR, Liu J, Wilson D, Chen Y, Thompson IM, Troyer DA, Hernandez J, Shi H, Leach RJ, Huang TH, Jin VX. Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis. Scientific Reports. 6: 22051. PMID 26924343 DOI: 10.1038/Srep22051 |
0.344 |
|
| 2016 |
Winchester DA, Gurel B, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Thompson IM, Xu J, Zheng SL, Lucia MS, Lippman SM, Parnes HL, Isaacs WB, et al. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial. The Prostate. PMID 26771888 DOI: 10.1002/Pros.23147 |
0.449 |
|
| 2016 |
Gelfond J, Choate K, Ankerst DP, Hernandez J, Leach RJ, Thompson IM. Intermediate-term risk of prostate cancer is directly related to baseline prostate specific antigen: Implications for reducing the burden of prostate specific antigen screening Journal of Urology. 194: 46-51. PMID 25686543 DOI: 10.1016/J.Juro.2015.02.043 |
0.433 |
|
| 2016 |
Ashcraft KA, Johnson-Pais TL, Gelfond JAL, Hernandez J, Thompson IM, Leach RJ. Abstract 4949: 18q copy number variation in primary prostate tumors as a predictor of long-term outcome Cancer Research. 76: 4949-4949. DOI: 10.1158/1538-7445.Am2016-4949 |
0.431 |
|
| 2016 |
Shi T, Gao Y, Qian W, Leach R, Thompson I, Quek S, Ellis W, Vitello E, Liu A. S&T-10 Prostate Cancer Diagnosis By Multiple Secreted Protein Biomarkers In Voided Urine The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2839 |
0.412 |
|
| 2015 |
Ankerst DP, Liss M, Zapata D, Hoefler J, Thompson IM, Leach RJ. A case control study of sarcosine as an early prostate cancer detection biomarker. Bmc Urology. 15: 99. PMID 26429735 DOI: 10.1186/S12894-015-0095-5 |
0.409 |
|
| 2015 |
Horning AM, Awe JA, Wang CM, Liu J, Lai Z, Wang VY, Jadhav RR, Louie AD, Lin CL, Kroczak T, Chen Y, Jin VX, Abboud-Werner SL, Leach RJ, Hernandez J, et al. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. The Prostate. PMID 26332453 DOI: 10.1002/Pros.23052 |
0.377 |
|
| 2015 |
Quek SI, Wong OM, Chen A, Borges GT, Ellis WJ, Salvanha DM, Vêncio RZ, Weaver B, Ench YM, Leach RJ, Thompson IM, Liu AY. Processing of voided urine for prostate cancer RNA biomarker analysis. The Prostate. PMID 26306723 DOI: 10.1002/Pros.23066 |
0.351 |
|
| 2015 |
Kulla E, Chou J, Simmons G, Wong J, McRae MP, Patel R, Floriano PN, Christodoulides N, Leach RJ, Thompson IM, McDevitt JT. Enhancement of performance in porous bead-based microchip sensors: Effects of chip geometry on bio-agent capture. Rsc Advances. 5: 48194-48206. PMID 26097696 DOI: 10.1039/C5Ra07910A |
0.302 |
|
| 2015 |
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng SL, Thompson IM, Lucia MS, Lippmann SM, Parnes HL, Dluzniewski PJ, Isaacs WB, et al. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial. The Prostate. PMID 26047319 DOI: 10.1002/Pros.23021 |
0.454 |
|
| 2015 |
Strobl AN, Vickers AJ, Van Calster B, Steyerberg E, Leach RJ, Thompson IM, Ankerst DP. Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators. Journal of Biomedical Informatics. 56: 87-93. PMID 25989018 DOI: 10.1016/J.Jbi.2015.05.001 |
0.399 |
|
| 2015 |
Chau CH, Price DK, Till C, Goodman PJ, Chen X, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Tangen CM, Chu L, Parnes HL, Schenk JM, Reichardt JK, Thompson IM, et al. Finasteride concentrations and prostate cancer risk: results from the prostate cancer prevention trial. Plos One. 10: e0126672. PMID 25955319 DOI: 10.1371/Journal.Pone.0126672 |
0.44 |
|
| 2015 |
Grill S, Fallah M, Leach RJ, Thompson IM, Hemminki K, Ankerst DP. A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation. Journal of Clinical Epidemiology. 68: 563-73. PMID 25684153 DOI: 10.1016/J.Jclinepi.2015.01.006 |
0.442 |
|
| 2015 |
Overholser S, Nielsen M, Torkko K, Cwilka D, Weaver B, Shi X, Leach RJ, Hernandez J, Huang T, Thompson IM, Thompson IM. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing. The Journal of Urology. PMID 25636657 DOI: 10.1016/J.Juro.2015.01.089 |
0.426 |
|
| 2015 |
Grill S, Fallah M, Leach RJ, Thompson IM, Freedland S, Hemminki K, Ankerst DP. Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator. The Journal of Urology. 193: 460-5. PMID 25242395 DOI: 10.1016/J.Juro.2014.09.018 |
0.381 |
|
| 2015 |
Liss MA, Ankerst D, Zapata D, Hernandez J, Leach RJ, Thompson IM. Prevalence of Isolated "Pre-Malignant" Lesions on Prostate Biopsy in a Racially Diverse Community Screened Cohort Open Journal of Urology. 5: 213-219. DOI: 10.4236/Oju.2015.512034 |
0.431 |
|
| 2015 |
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng SL, Thompson IM, Lucia MS, Lippmann SM, Parnes HL, Dluzniewski PJ, Isaacs WB, et al. Abstract 4605: Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial Cancer Research. 75: 4605-4605. DOI: 10.1158/1538-7445.Am2015-4605 |
0.438 |
|
| 2015 |
Choate K, Gelfond J, Ankerst D, Hernandez J, Leach R, Thompson I. Mp77-09 Long-Term Risk Of Prostate Cancer Is Directly Related To Baseline Psa: The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.549 |
0.405 |
|
| 2015 |
Patil D, Calle Cdl, Weaver B, Leach R, Thompson I, Sokoll L, Chan D, Groskopf J, Carter JJ, Torlak M, Sanda M. Pd46-05 Multi-Center Prospective Study Of Urine Rna Testing As A Strategy For Prostate Cancer Screening: Collaboration Between Urology, Primary Care, And Community Outreach The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2736 |
0.322 |
|
| 2014 |
Thompson IM, Leach RJ, Ankerst DP. Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision making. Jama. 312: 995-6. PMID 25090603 DOI: 10.1001/Jama.2014.9680 |
0.384 |
|
| 2014 |
Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM. Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer Urology. 83: 1362-1367. PMID 24862395 DOI: 10.1016/J.Urology.2014.02.035 |
0.44 |
|
| 2014 |
Figg WD, Chau CH, Price DK, Till C, Goodman PJ, Cho Y, Varella-Garcia M, Reichardt JK, Tangen CM, Leach RJ, van Bokhoven A, Thompson IM, Lucia MS. Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial. Urology. 84: 127-31. PMID 24824408 DOI: 10.1016/J.Urology.2014.03.015 |
0.454 |
|
| 2014 |
Medina EA, Shi X, Grayson MH, Ankerst DP, Livi CB, Medina MV, Thompson IM, Leach RJ. The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancer Cancer Epidemiology Biomarkers and Prevention. 23: 309-315. PMID 24296854 DOI: 10.1158/1055-9965.Epi-13-0574 |
0.444 |
|
| 2014 |
Blackburn A, Wilson D, Gelfond J, Yao L, Hernandez J, Thompson IM, Leach RJ, Lehman DM. Validation of copy number variants associated with prostate cancer risk and prognosis. Urologic Oncology. 32: 44.e15-20. PMID 24054869 DOI: 10.1016/J.Urolonc.2013.06.004 |
0.433 |
|
| 2014 |
Hariharan N, Svatek RS, Livi CB, Gelfond JAL, Johnson-Pais TL, Leach RJ. Abstract 192: Role of adipose tissue in bladder cancer progression Cancer Research. 74: 192-192. DOI: 10.1158/1538-7445.Am2014-192 |
0.349 |
|
| 2014 |
Price DK, Chau CH, Figg WD, Till CA, Goodman PJ, Cho Y, Garcia M, Reichardt J, Tangen CM, Leach RJ, Bokhoven Av, Kristal AR, Thompson IM, Lucia MS. Abstract 1863: Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results from the Prostate Cancer Prevention Trial Cancer Research. 74: 1863-1863. DOI: 10.1158/1538-7445.Am2014-1863 |
0.445 |
|
| 2014 |
Chen H, Sun J, Ankerst D, Leach R, Goodman P, Lucia S, Tangen C, Isaacs W, Zheng SL, Thompson I, Platz E, Xu J. MP69-12 ADDED VALUE OF GENETIC RISK SCORE TO THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR: FINDINGS FROM THE PCPT STUDY Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2231 |
0.402 |
|
| 2013 |
Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, ... ... Leach RJ, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013: 560857. PMID 23476788 DOI: 10.1155/2013/560857 |
0.376 |
|
| 2013 |
Thompson IM, Leach R. Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 515-6. PMID 23295801 DOI: 10.1200/Jco.2012.46.6151 |
0.443 |
|
| 2013 |
Chen CL, Mahalingam D, Osmulski P, Jadhav RR, Wang CM, Leach RJ, Chang TC, Weitman SD, Kumar AP, Sun L, Gaczynska ME, Thompson IM, Huang TH. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. The Prostate. 73: 813-26. PMID 23280481 DOI: 10.1002/Pros.22625 |
0.406 |
|
| 2012 |
Hilton WM, Padalecki SS, Ankerst DP, Leach RJ, Thompson IM. Temporal changes in the clinical approach to diagnosing prostate cancer. Journal of the National Cancer Institute. Monographs. 2012: 162-8. PMID 23271768 DOI: 10.1093/Jncimonographs/Lgs038 |
0.428 |
|
| 2012 |
Leach R, Thompson IM. The dilemma of prostate-specific antigen testing. Archives of Internal Medicine. 172: 835-6. PMID 22905350 DOI: 10.1001/Archinternmed.2012.1226 |
0.324 |
|
| 2012 |
Ankerst DP, Koniarski T, Liang Y, Leach RJ, Feng Z, Sanda MG, Partin AW, Chan DW, Kagan J, Sokoll L, Wei JT, Thompson IM. Updating risk prediction tools: a case study in prostate cancer. Biometrical Journal. Biometrische Zeitschrift. 54: 127-42. PMID 22095849 DOI: 10.1002/Bimj.201100062 |
0.332 |
|
| 2011 |
Mitra N, Banda K, Altheide TK, Schaffer L, Johnson-Pais TL, Beuten J, Leach RJ, Angata T, Varki N, Varki A. SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas. The Journal of Biological Chemistry. 286: 23003-11. PMID 21555517 DOI: 10.1074/Jbc.M111.244152 |
0.394 |
|
| 2011 |
Ankerst DP, Pollock BH, Liang Y, Dizdarevic N, Kyrylenko S, Boeck A, Thompson IM, Leach R. Trends and co-trends of prostate-specific antigen and body mass index in a screened population. Urology. 78: 10-6. PMID 21550639 DOI: 10.1016/J.Urology.2011.01.069 |
0.354 |
|
| 2011 |
Thompson IM, Leach RJ, Ankerst DP. Prostate cancer detection: a view of the future. European Urology. 59: 191-3. PMID 21130561 DOI: 10.1016/J.Eururo.2010.11.019 |
0.419 |
|
| 2011 |
Liang Y, Ankerst DP, Ketchum NS, Ercole B, Shah G, Shaughnessy JD, Leach RJ, Thompson IM. Prospective evaluation of operating characteristics of prostate cancer detection biomarkers. The Journal of Urology. 185: 104-10. PMID 21074193 DOI: 10.1016/J.Juro.2010.08.088 |
0.424 |
|
| 2011 |
Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, ... ... Leach RJ, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 23-32. PMID 21071540 DOI: 10.1158/1055-9965.Epi-10-0698 |
0.427 |
|
| 2011 |
Ercole B, Livi CB, Price DK, Torkko KC, Drake JM, Cantrill CH, Thompson IM, Leach RJ. 1442 Constitutional Genetic Variation Associated With Prostate Cancer Progression The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1355 |
0.423 |
|
| 2010 |
Liang Y, Ankerst DP, Sanchez M, Leach RJ, Thompson IM. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening. Urology. 76: 1268.e1-6. PMID 20739049 DOI: 10.1016/J.Urology.2010.04.060 |
0.413 |
|
| 2010 |
Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, Morales-Rodriguez IB, Hernandez-Ordoñez MA, Calderon-Cardenas G, Ortiz-Lopez R, Rivas-Estilla AM, Ancer-Rodriguez J, Rojas-Martinez A. Identification of viral infections in the prostate and evaluation of their association with cancer. Bmc Cancer. 10: 326. PMID 20576103 DOI: 10.1186/1471-2407-10-326 |
0.441 |
|
| 2010 |
Beuten J, Gelfond JA, Franke JL, Shook S, Johnson-Pais TL, Thompson IM, Leach RJ. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 588-99. PMID 20086112 DOI: 10.1158/1055-9965.Epi-09-0864 |
0.462 |
|
| 2009 |
Beuten J, Garcia D, Brand TC, He X, Balic I, Canby-Hagino E, Troyer DA, Baillargeon J, Hernandez J, Thompson IM, Leach RJ, Naylor SL. Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis. The Journal of Urology. 182: 1614-20. PMID 19683737 DOI: 10.1016/J.Juro.2009.06.016 |
0.36 |
|
| 2009 |
Beuten J, Gelfond JA, Martinez-Fierro ML, Weldon KS, Crandall AC, Rojas-Martinez A, Thompson IM, Leach RJ. Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. Carcinogenesis. 30: 1372-9. PMID 19528667 DOI: 10.1093/Carcin/Bgp148 |
0.404 |
|
| 2009 |
Beuten J, Gelfond JA, Franke JL, Weldon KS, Crandall AC, Johnson-Pais TL, Thompson IM, Leach RJ. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1869-80. PMID 19505920 DOI: 10.1158/1055-9965.Epi-09-0076 |
0.437 |
|
| 2009 |
Sarvis JA, Beuten J, Leach RJ, Thompson IM. Evaluating The Role Of Diabetes And The Diabetes Related Gene, Tcf2, In Prostate Cancer Risk Among African-American, Caucasian, And Hispanic Men The Journal of Urology. 181: 206-206. DOI: 10.1016/S0022-5347(09)60592-9 |
0.365 |
|
| 2008 |
Ankerst DP, Groskopf J, Day JR, Blase A, Rittenhouse H, Pollock BH, Tangen C, Parekh D, Leach RJ, Thompson I. Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3 Journal of Urology. 180: 1303-1308. PMID 18707724 DOI: 10.1016/J.Juro.2008.06.038 |
0.452 |
|
| 2008 |
Reed AB, Ankerst DP, Leach RJ, Vipraio G, Thompson IM, Parekh DJ. Total Prostate Specific Antigen Stability Confirmed After Long-Term Storage of Serum at -80C Journal of Urology. 180: 534-538. PMID 18550121 DOI: 10.1016/J.Juro.2008.04.021 |
0.39 |
|
| 2008 |
Beuten J, Gelfond JA, Byrne JJ, Balic I, Crandall AC, Johnson-Pais TL, Thompson IM, Price DK, Leach RJ. CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. Carcinogenesis. 29: 1751-7. PMID 18544568 DOI: 10.1093/Carcin/Bgm300 |
0.314 |
|
| 2008 |
Torkko KC, van Bokhoven A, Mai P, Beuten J, Balic I, Byers TE, Hokanson JE, Norris JM, Barón AE, Lucia MS, Thompson IM, Leach RJ. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3223-9. PMID 18483391 DOI: 10.1158/1078-0432.Ccr-07-4894 |
0.429 |
|
| 2008 |
Rhodes EC, Johnson-Pais TL, Singer FR, Ankerst DP, Bruder JM, Wisdom J, Hoon DS, Lin E, Bone HG, Simcic KJ, Leach RJ. Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States. Calcified Tissue International. 82: 271-7. PMID 18379713 DOI: 10.1007/S00223-008-9114-9 |
0.65 |
|
| 2008 |
Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS. Maspin reduces prostate cancer metastasis to bone Urologic Oncology: Seminars and Original Investigations. 26: 652-658. PMID 18367129 DOI: 10.1016/J.Urolonc.2007.07.017 |
0.379 |
|
| 2008 |
Brand TC, Bermejo C, Canby-Hagino E, Troyer DA, Baillargeon J, Thompson IM, Leach RJ, Naylor SL. Association of polymorphisms in TGFB1 and prostate cancer prognosis. The Journal of Urology. 179: 754-8. PMID 18082198 DOI: 10.1016/J.Juro.2007.09.020 |
0.442 |
|
| 2008 |
Parekh DJ, Schraudenbach PT, Ankerst DP, Lokshin AE, Baillargeon J, Higgins B, Platz EA, Troyer DA, Hernandez J, Leach R, Thompson IM. A CASE-CONTROL STUDY OF FIFTY-FOUR BIOMARKERS OF PROSTATE CANCER Journal of Urology. 179: 605-605. DOI: 10.1016/S0022-5347(08)61772-3 |
0.405 |
|
| 2007 |
Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, Thompson IM, Leach RJ, Parekh DJ. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL. Urology. 70: 748-52. PMID 17991549 DOI: 10.1016/J.Urology.2007.06.1105 |
0.431 |
|
| 2007 |
Parekh DJ, Ankerst DP, Baillargeon J, Higgins B, Platz EA, Troyer D, Hernandez J, Leach RJ, Lokshin A, Thompson IM. Assessment of 54 biomarkers for biopsy-detectable prostate cancer Cancer Epidemiology Biomarkers and Prevention. 16: 1966-1972. PMID 17932343 DOI: 10.1158/1055-9965.Epi-07-0302 |
0.433 |
|
| 2007 |
Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5959-64. PMID 17908993 DOI: 10.1158/1078-0432.Ccr-07-0702 |
0.46 |
|
| 2007 |
Chavarría-Siles I, Walss-Bass C, Quezada P, Dassori A, Contreras S, Medina R, Ramírez M, Armas R, Salazar R, Leach RJ, Raventos H, Escamilla MA. TGFB-induced factor (TGIF): a candidate gene for psychosis on chromosome 18p. Molecular Psychiatry. 12: 1033-41. PMID 17440433 DOI: 10.1038/Sj.Mp.4001997 |
0.353 |
|
| 2007 |
Lee BD, Walss-Bass C, Thompson PM, Dassori A, Montero PA, Medina R, Contreras S, Armas R, Ramirez M, Pereira M, Salazar R, Leach RJ, Quezada P, Raventos H, Escamilla MA. Malic enzyme 2 and susceptibility to psychosis and mania. Psychiatry Research. 150: 1-11. PMID 17258816 DOI: 10.1016/J.Psychres.2006.06.001 |
0.318 |
|
| 2006 |
Parekh DJ, Ankerst DP, Higgins BA, Hernandez J, Canby-Hagino E, Brand T, Troyer DA, Leach RJ, Thompson IM. External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population. Urology. 68: 1152-5. PMID 17169636 DOI: 10.1016/J.Urology.2006.10.022 |
0.426 |
|
| 2006 |
Lehman DM, Leach RJ, Johnson-Pais T, Hamlington J, Fowler S, Almasy L, Duggirala R, Stern MP, Abboud HE. Evaluation of tight junction protein 1 encoding zona occludens 1 as a candidate gene for albuminuria in a Mexican American population. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 114: 432-7. PMID 17039425 DOI: 10.1055/S-2006-924328 |
0.312 |
|
| 2006 |
Brand TC, Canby-Hagino ED, Pratap Kumar A, Ghosh R, Leach RJ, Thompson IM. Chemoprevention of prostate cancer. Hematology/Oncology Clinics of North America. 20: 831-43. PMID 16861117 DOI: 10.1016/J.Hoc.2006.03.012 |
0.438 |
|
| 2006 |
Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM. Obesity, adipokines, and prostate cancer in a prospective population-based study Cancer Epidemiology Biomarkers and Prevention. 15: 1331-1335. PMID 16835332 DOI: 10.1158/1055-9965.Epi-06-0082 |
0.381 |
|
| 2006 |
Walss-Bass C, Montero AP, Armas R, Dassori A, Contreras SA, Liu W, Medina R, Levinson D, Pereira M, Atmella I, NeSmith L, Leach R, Almasy L, Raventos H, Escamilla MA. Linkage disequilibrium analyses in the Costa Rican population suggests discrete gene loci for schizophrenia at 8p23.1 and 8q13.3. Psychiatric Genetics. 16: 159-68. PMID 16829783 DOI: 10.1097/01.Ypg.0000218616.27515.67 |
0.341 |
|
| 2006 |
Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D, Xiang R, Leach RJ, Johnson-Pais TL, Naylor SL. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization. Cancer Research. 66: 4055-64. PMID 16618725 DOI: 10.1158/0008-5472.Can-05-3822 |
0.483 |
|
| 2006 |
Vaurs-Barriere C, Bonnet-Dupeyron MN, Combes P, Gauthier-Barichard F, Reveles XT, Schiffmann R, Bertini E, Rodriguez D, Vago P, Armour JA, Saugier-Veber P, Frebourg T, Leach RJ, Boespflug-Tanguy O. Golli-MBP copy number analysis by FISH, QMPSF and MAPH in 195 patients with hypomyelinating leukodystrophies. Annals of Human Genetics. 70: 66-77. PMID 16441258 DOI: 10.1111/J.1529-8817.2005.00208.X |
0.306 |
|
| 2006 |
Hernández J, Balic I, Johnson-Pais TL, Higgins BA, Torkko KC, Thompson IM, Leach RJ. Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. The Journal of Urology. 175: 523-7. PMID 16406987 DOI: 10.1016/S0022-5347(05)00240-5 |
0.429 |
|
| 2006 |
Canby-Hagino ED, Garda D, Thompson lM, Troyer D, Baillargeon J, Brand TC, Leach R, Naylor SL. 821: The VEGF+405 CC Polymorphism is Associated with Prostate Cancers of Poor Prognosis The Journal of Urology. 175: 265-265. DOI: 10.1016/S0022-5347(18)33057-X |
0.422 |
|
| 2006 |
Torkko KC, Mai P, Leach RJ, Higgins BA, Van Bokhoven A, Byers TE, Hokanson JE, Norris JM, Barón AE, Thompson IM, Lucia MS. 487: Vitamin D Receptor Gene Haplotypes and Prostate Cancer in Hispanic and Non-Hispanic White Men: Results from a Case-Control Genetic Association Study Journal of Urology. 175: 158-158. DOI: 10.1016/S0022-5347(18)32743-5 |
0.398 |
|
| 2006 |
Brand TC, Garcia D, Canby-Hagino E, Thompson IM, Troyer D, Baillargeon J, Leach R, Naylor SL. 242: Variants of Semaphorin 3F are Associated with Prostate Cancer Prognosis The Journal of Urology. 175: 80-80. DOI: 10.1016/S0022-5347(18)32509-6 |
0.399 |
|
| 2005 |
Walss-Bass C, Escamilla MA, Raventos H, Montero AP, Armas R, Dassori A, Contreras S, Liu W, Medina R, Balderas TG, Levinson D, Pereira R, Pereira M, Atmella I, Nesmith L, ... Leach R, et al. Evidence of genetic overlap of schizophrenia and bipolar disorder: linkage disequilibrium analysis of chromosome 18 in the Costa Rican population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 139: 54-60. PMID 16152570 DOI: 10.1002/Ajmg.B.30207 |
0.356 |
|
| 2005 |
Schaub RL, Hale DE, Rose SR, Leach RJ, Cody JD. The spectrum of thyroid abnormalities in individuals with 18q deletions Journal of Clinical Endocrinology and Metabolism. 90: 2259-2263. PMID 15671099 DOI: 10.1210/Jc.2004-1630 |
0.329 |
|
| 2005 |
Naylor SL, He X, Xiang R, Garcia DK, Canby-Hagino ED, Baillargeon J, Hernandez J, Troyer DA, Thompson IM, Leach RJ. 1414: Aggressive Prostate Cancer is Associated with Nucleotide Variants of the Semaphorin 3F Gene The Journal of Urology. 173: 383-383. DOI: 10.1016/S0022-5347(18)35548-4 |
0.416 |
|
| 2005 |
Hernandez J, Batie I, Johnson-Pais TL, Thompson IM, Leach RJ. 404: P53 ARG72PRO Single Nucleotide Polymorphism (SNP) is Associated with Increased Risk for Prostate Cancer Among African American Men The Journal of Urology. 173: 110-111. DOI: 10.1016/S0022-5347(18)34657-3 |
0.407 |
|
| 2004 |
Troyer DA, Mubiru J, Leach RJ, Naylor SL. Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis. Disease Markers. 20: 117-128. PMID 15322319 DOI: 10.1155/2004/509276 |
0.449 |
|
| 2004 |
Thompson IM, Leach R, Troyer D, Pollock B, Naylor S, Higgins B. Relationship of body mass index and prostate specific antigen in a population-based study Urologic Oncology: Seminars and Original Investigations. 22: 127-131. PMID 15082010 DOI: 10.1016/S1078-1439(03)00171-6 |
0.394 |
|
| 2004 |
Syed S, Tolcher A, Troyer D, Furman J, Leach R, Thompson IM. Adjuvant therapy in prostate cancer: Patient identification and treatment options Urooncology. 4: 119-126. DOI: 10.1080/15610950410001732294 |
0.352 |
|
| 2003 |
Grizzle WE, Adam BL, Bigbee WL, Conrads TP, Carroll C, Feng Z, Izbicka E, Jendoubi M, Johnsey D, Kagan J, Leach RJ, McCarthy DB, Semmes OJ, Srivastava S, Srivastava S, et al. Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. Disease Markers. 19: 185-95. PMID 15258333 DOI: 10.1155/2004/546293 |
0.337 |
|
| 2003 |
Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B. Prostate cancer prevention: what do we know now and when will we know more? Clinical Prostate Cancer. 1: 215-20. PMID 15040879 DOI: 10.3816/Cgc.2003.N.002 |
0.399 |
|
| 2003 |
Padalecki SS, Weldon KS, Reveles XT, Buller CL, Grubbs B, Cui Y, Yin JJ, Hall DC, Hummer BT, Weissman BE, Dallas M, Guise TA, Leach RJ, Johnson-Pais TL. Chromosome 18 suppresses prostate cancer metastases. Urologic Oncology. 21: 366-73. PMID 14670546 DOI: 10.1016/S1078-1439(03)00013-9 |
0.418 |
|
| 2003 |
Thompson I, Leach RJ, Pollock BH, Naylor SL. Prostate cancer and prostate-specific antigen: the more we know, the less we understand. Journal of the National Cancer Institute. 95: 1027-8. PMID 12865440 DOI: 10.1093/Jnci/95.14.1027 |
0.42 |
|
| 2003 |
Gunn SR, Mohammed M, Reveles XT, Viskochil DH, Palumbos JC, Johnson-Pais TL, Hale DE, Lancaster JL, Hardies LJ, Boespflug-Tanguy O, Cody JD, Leach RJ. Molecular characterization of a patient with central nervous system dysmyelination and cryptic unbalanced translocation between chromosomes 4q and 18q. American Journal of Medical Genetics. Part A. 120: 127-35. PMID 12794705 DOI: 10.1002/Ajmg.A.20026 |
0.691 |
|
| 2003 |
Schneider BG, Rha SY, Chung HC, Bravo JC, Mera R, Torres JC, Plaisance KT, Schlegel R, McBride CM, Reveles XT, Leach RJ. Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer. Molecular Pathology : Mp. 56: 141-9. PMID 12782760 DOI: 10.1136/Mp.56.3.141 |
0.355 |
|
| 2003 |
Leach R, Pollock B, Basler J, Troyer D, Naylor S, Thompson IM. Chemoprevention of prostate cancer: Focus on key opportunities and clinical trials Urologic Clinics of North America. 30: 227-237. PMID 12735500 DOI: 10.1016/S0094-0143(02)00178-7 |
0.413 |
|
| 2003 |
Thompson IM, Basler JA, Leach R, Troyer D, Klein E, Brawley O. Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer Urologic Oncology: Seminars and Original Investigations. 21: 73-78. PMID 12684131 DOI: 10.1016/S1078-1439(02)00302-2 |
0.402 |
|
| 2003 |
Johnson-Pais TL, Nellissery MJ, Ammerman DG, Pathmanathan D, Bhatia P, Buller CL, Leach RJ, Hansen MF. Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma. International Journal of Cancer. 105: 285-8. PMID 12673693 DOI: 10.1002/Ijc.11070 |
0.371 |
|
| 2002 |
Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. The Journal of Urology. 168: 2245-8. PMID 12394768 DOI: 10.1016/S0022-5347(05)64364-9 |
0.445 |
|
| 2002 |
Schaub RL, Reveles XT, Baillargeon J, Leach RJ, Cody JD. Molecular characterization of 18p deletions: Evidence for a breakpoint cluster Genetics in Medicine. 4: 15-19. PMID 11839953 DOI: 10.1097/00125817-200201000-00003 |
0.312 |
|
| 2001 |
Lehman DM, Sponsel WE, Stratton RF, Mensah J, Macdonald JC, Johnson-Pais TL, Coon H, Reveles XT, Cody JD, Leach RJ. Genetic mapping of a novel X-linked recessive colobomatous microphthalmia. American Journal of Medical Genetics. 101: 114-9. PMID 11391653 DOI: 10.1002/Ajmg.1330 |
0.323 |
|
| 2001 |
Padalecki SS, Johnson-Pais TL, Killary AM, Leach RJ. Chromosome 18 suppresses the tumorigenicity of prostate cancer cells. Genes, Chromosomes & Cancer. 30: 221-9. PMID 11170278 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1093>3.0.Co;2-L |
0.447 |
|
| 2000 |
Schaub R, Dupont B, Roodman GD, Leach RJ, Reddy SV. Assignment of OSTF1 to human chromosome bands 12q24.1-->q24.2 by in situ hybridization. Cytogenetics and Cell Genetics. 88: 87-8. PMID 10773673 DOI: 10.1159/000015492 |
0.325 |
|
| 2000 |
Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP. A major susceptibility locus influencing plasma triglyceride concentrations is located chromosome 15q in Mexican Americans American Journal of Human Genetics. 66: 1237-1245. PMID 10729112 DOI: 10.1086/302849 |
0.377 |
|
| 2000 |
Padalecki SS, Troyer DA, Hansen MF, Saric T, Schneider BG, O'Connell P, Leach RJ. Identification of two distinct regions of allelic imbalance on chromosome 18q in metastatic prostate cancer International Journal of Cancer. 85: 654-658. PMID 10699945 DOI: 10.1002/(Sici)1097-0215(20000301)85:5<654::Aid-Ijc10>3.0.Co;2-D |
0.455 |
|
| 1999 |
Cody JD, Reveles XT, Hale DE, Lehman D, Coon H, Leach RJ. Haplosufficiency of the melanocortin-4 receptor gene in individuals with deletions of 18q Human Genetics. 105: 424-427. PMID 10598807 DOI: 10.1007/S004390051125 |
0.311 |
|
| 1999 |
Wang Z, Cody JD, Leach RJ, O'Connell P. Gene expression patterns in cell lines from patients with 18q- syndrome. Human Genetics. 104: 467-475. PMID 10453734 DOI: 10.1007/S004390050989 |
0.304 |
|
| 1999 |
Cody JD, Ghidoni PD, DuPont BR, Hale DE, Hilsenbeck SG, Stratton RF, Hoffman DS, Muller S, Schaub RL, Leach RJ, Kaye CI. Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. American Journal of Medical Genetics. 85: 455-62. PMID 10405442 DOI: 10.1002/(Sici)1096-8628(19990827)85:5<455::Aid-Ajmg5>3.0.Co;2-Z |
0.363 |
|
| 1999 |
MacDougall M, Jeffords LG, Gu TT, Knight CB, Frei G, Reus BE, Otterud B, Leppert M, Leach RJ. Genetic linkage of the dentinogenesis imperfecta type III locus to chromosome 4q. Journal of Dental Research. 78: 1277-82. PMID 10371253 DOI: 10.1177/00220345990780061301 |
0.355 |
|
| 1999 |
Saric T, Brkanac Z, Troyer DA, Padalecki SS, Sarosdy M, Williams K, Abadesco L, Leach RJ, O'Connell P. Genetic pattern of prostate cancer progression. International Journal of Cancer. 81: 219-224. PMID 10188722 DOI: 10.1002/(Sici)1097-0215(19990412)81:2<219::Aid-Ijc9>3.0.Co;2-3 |
0.442 |
|
| 1999 |
Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans American Journal of Human Genetics. 64: 1127-1140. PMID 10090898 DOI: 10.1086/302316 |
0.307 |
|
| 1999 |
Cody JD, Ghidoni PD, Dupont BR, Hale DE, Hilsenbeck SG, Stratton RF, Hoffman DS, Muller S, Schaub RL, Leach RJ, Kaye CI. Congenital Anomalies and Anthropometry of 42 Individuals with Deletions of Chromosome 18q Pediatric Research. 45: 136-136. DOI: 10.1203/00006450-199904020-00811 |
0.34 |
|
| 1999 |
Sekhon GS, Scheib-Wixted S, Williams MS, Reveles XT, Leach RJ. A small paracentric inversion of chromosome 18, inv(18) (q22.1q23), in a woman with multiple congenital anomalies and mental retardation Genetics in Medicine. 1: 69-69. DOI: 10.1097/00125817-199901000-00112 |
0.35 |
|
| 1998 |
Sakaguchi AY, Padalecki SS, Mattern V, Rodriguez A, Leach RJ, McGill JR, Chavez M, Giambernardi TA. Chromosomal sublocalization of the transcribed human telomere repeat binding factor 2 gene and comparative mapping in the mouse. Somatic Cell and Molecular Genetics. 24: 157-63. PMID 10226653 DOI: 10.1023/B:Scam.0000007118.47691.D7 |
0.346 |
|
| 1998 |
Nellissery MJ, Padalecki SS, Brkanac Z, Singer FR, Roodman GD, Unni KK, Leach RJ, Hansen MF. Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. American Journal of Human Genetics. 63: 817-24. PMID 9718349 DOI: 10.1086/302019 |
0.354 |
|
| 1998 |
Yao YL, Dupont BR, Ghosh S, Fang Y, Leach RJ, Seto E. Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1. Nucleic Acids Research. 26: 3776-83. PMID 9685495 DOI: 10.1093/Nar/26.16.3776 |
0.305 |
|
| 1998 |
Brkanac Z, Cody JD, Leach RJ, DuPont BR. Identification of cryptic rearrangements in patients with 18q- deletion syndrome American Journal of Human Genetics. 62: 1500-1506. PMID 9585582 DOI: 10.1086/301854 |
0.356 |
|
| 1998 |
Keppler-Noreuil KM, Carroll AJ, Finley SC, Descartes M, Cody JD, DuPont BR, Gay CT, Leach RJ. Chromosome 18q paracentric inversion in a family with mental retardation and hearing loss. American Journal of Medical Genetics. 76: 372-8. PMID 9556294 DOI: 10.1002/(Sici)1096-8628(19980413)76:5<372::Aid-Ajmg2>3.0.Co;2-P |
0.353 |
|
| 1998 |
Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nature Genetics. 18: 53-5. PMID 9425900 DOI: 10.1038/Ng0198-53 |
0.362 |
|
| 1997 |
Cody JD, Singer FR, Roodman GD, Otterund B, Lewis TB, Leppert M, Leach RJ. Genetic linkage of Paget disease of the bone to chromosome 18q. American Journal of Human Genetics. 61: 1117-22. PMID 9345096 DOI: 10.1086/301601 |
0.36 |
|
| 1997 |
Simoneaux DK, Leach RJ, O’Connell P. Galanin receptor 1 gene (Galnr1) is tightly linked to the myelin basic protein gene on Chromosome 18 in mouse Mammalian Genome. 8: 875-875. PMID 9337411 DOI: 10.1007/S003359900630 |
0.311 |
|
| 1997 |
Cody JD, Hale DE, Brkanac Z, Kaye CI, Leach RJ. Growth hormone insufficiency associated with haploinsufficiency at 18q23. American Journal of Medical Genetics. 71: 420-5. PMID 9286448 DOI: 10.1002/(Sici)1096-8628(19970905)71:4<420::Aid-Ajmg9>3.0.Co;2-X |
0.303 |
|
| 1997 |
MacDougall M, DuPont BR, Simmons D, Reus B, Krebsbach P, Kärrman C, Holmgren G, Leach RJ, Forsman K. Ameloblastin gene (AMBN) maps within the critical region for autosomal dominant amelogenesis imperfecta at chromosome 4q21. Genomics. 41: 115-8. PMID 9126491 DOI: 10.1006/Geno.1997.4643 |
0.372 |
|
| 1997 |
Cody JD, Pierce JF, Brkanac Z, Plaetke R, Ghidoni PD, Kaye CI, Leach RJ. Preferential loss of the paternal alleles in the 18q- syndrome. American Journal of Medical Genetics. 69: 280-6. PMID 9096757 DOI: 10.1002/(Sici)1096-8628(19970331)69:3<280::Aid-Ajmg12>3.0.Co;2-N |
0.347 |
|
| 1996 |
Johnson-Pais TL, Leach RJ. Regional Mapping Strategies Utilizing Microcell Hybrids Methods. 9: 20-29. PMID 9245339 DOI: 10.1006/Meth.1996.0004 |
0.326 |
|
| 1996 |
Leach RJ, Banga SS, Ben-Othame K, Chughtai S, Clarke R, Daiger SP, Kolehmainen J, Kumar S, Kuo M, Macoska J, Mada N, Naylor SL, Nunes M, O'Connell P, Pebusque MJ, et al. Report of the Third International Workshop on Human Chromosome 8 Mapping. San Antonio, Texas, October 25-27, 1996. Cytogenetics and Cell Genetics. 75: 71-84. PMID 9040775 DOI: 10.1159/000134460 |
0.305 |
|
| 1996 |
Linn R, DuPont BR, Knight CB, Plaetke R, Leach RJ. Reassignment of the 92-kDa type IV collagenase gene (CLG4B) to human chromosome 20. Cytogenetic and Genome Research. 72: 159-161. PMID 8978762 DOI: 10.1159/000134175 |
0.34 |
|
| 1996 |
MacDougall M, DuPont BR, Simmons D, Leach RJ. Assignment of DMP1 to human chromosome 4 band q21 by in situ hybridization. Cytogenetics and Cell Genetics. 74: 189. PMID 8941370 DOI: 10.1159/000134410 |
0.321 |
|
| 1996 |
Yoshikawa T, Brkanac Z, Dupont BR, Xing GQ, Leach RJ, Detera-Wadleigh SD. Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2. Genomics. 35: 637-638. PMID 8812511 DOI: 10.1006/Geno.1996.0417 |
0.316 |
|
| 1996 |
Lewis TB, Wood S, Michaelis EK, DuPont BR, Leach RJ. Localization of a gene for a glutamate binding subunit of a NMDA receptor (GRINA) to 8q24. Genomics. 32: 131-3. PMID 8786101 DOI: 10.1006/Geno.1996.0088 |
0.346 |
|
| 1996 |
Lewis TB, Shevell MI, Andermann E, Ryan SG, Leach RJ. Evidence of a third locus for benign familial convulsions. Journal of Child Neurology. 11: 211-4. PMID 8734025 DOI: 10.1177/088307389601100310 |
0.33 |
|
| 1996 |
Naylor SL, Carritt B, Boileau C, Beroud C, Alexander C, Allderdice P, Alimov A, Ashworth T, Bonifas J, Bugert P, Buys CH, Chipperfield MA, Deng G, Drabkin H, Gemmill RM, ... ... Leach RJ, et al. Report of the sixth international workshop on human chromosome 3 mapping 1995. Cytogenetics and Cell Genetics. 72: 255-70. PMID 8641130 DOI: 10.1159/000134204 |
0.304 |
|
| 1996 |
Naylor SL, Moore S, Garcia D, Xiang X, Xin X, Mohrer M, Reus B, Linn R, Stanton V, O'Connell P, Leach RJ. Mapping 638 STSs to regions of human chromosome 3 Cytogenetic and Genome Research. 72: 90-94. PMID 8565645 DOI: 10.1159/000134170 |
0.307 |
|
| 1995 |
Lewis TB, Nelson L, Ward K, Leach RJ. A radiation hybrid map of 40 loci for the distal long arm of human chromosome 8. Genome Research. 5: 334-41. PMID 8750193 DOI: 10.1101/Gr.5.4.334 |
0.32 |
|
| 1995 |
Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach R, Naylor S, Joenje H, Grompe M. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nature Genetics. 11: 341-3. PMID 7581463 DOI: 10.1038/Ng1195-341 |
0.353 |
|
| 1995 |
Leach RJ, O'Connell P. 3 Mapping of Mammalian Genomes with Radiation (Goss and Harris) Hybrids Advances in Genetics. 33: 63-99. PMID 7484458 DOI: 10.1016/S0065-2660(08)60331-4 |
0.316 |
|
| 1994 |
Lewis TB, Saenz M, O'Connell P, Leach RJ. Localization of glucose-dependent insulinotropic polypeptide (GIP) to a gene cluster on chromosome 17q. Genomics. 19: 589-91. PMID 8188305 DOI: 10.1006/Geno.1994.1114 |
0.336 |
|
| 1994 |
Leach RJ, Reus BE, Hundley JE, Johnson-Pais TL, Windle JJ. Confirmation of the assignment of the human tartrate-resistant acid phosphatase gene (ACP5) to chromosome 19 Genomics. 19: 180-181. PMID 8188227 DOI: 10.1006/Geno.1994.1037 |
0.341 |
|
| 1994 |
Legerski RJ, Liu P, Li L, Peterson CA, Zhao Y, Leach RJ, Naylor SL, Siciliano MJ. Assignment of xeroderma pigmentosum group C (XPC) gene to chromosome 3p25. Genomics. 21: 266-9. PMID 8088800 DOI: 10.1006/Geno.1994.1256 |
0.351 |
|
| 1994 |
Spurr NK, Blanton S, Bookstein R, Clarke R, Cottingham R, Daiger S, Drayna D, Faber P, Horrigan S, Kas K, Kirchgessner C, Kumar S, Leach RJ, Luedecke HJ, Nakamura Y, et al. Second International Workshop on Human Chromosome 8 Mapping 1994. Eynsham Hall, Oxford, UK, 16-18 September, 1994 Cytogenetics and Cell Genetics. 68: 147-164. PMID 7842731 DOI: 10.1159/000133908 |
0.303 |
|
| 1994 |
O'Connell P, Leach RJ, Rains D, Taylor T, Garcia D, Ballard L, Holik P, Weissenbach J, Sherman S, Wilkie P, Weber JL, Naylor SL. A PCR-Based Genetic Map for Human Chromosome 3 Genomics. 24: 557-567. PMID 7713508 DOI: 10.1006/Geno.1994.1666 |
0.33 |
|
| 1994 |
Leach RJ, Chinn R, Reus BE, Hayes S, Schantz L, Dubois B, Overhauser J, Ballabio A, Drabkin H, Lewis TB. Regional localization of 188 sequence tagged sites on a somatic cell hybrid mapping panel for human chromosome 3. Genomics. 24: 549-56. PMID 7713507 DOI: 10.1006/Geno.1994.1665 |
0.353 |
|
| 1994 |
Bookstein R, Levy A, MacGrogan D, Lewis TB, Weissenbach J, O'Connell P, Leach RJ. Yeast artificial chromosome and radiation hybrid map of loci in chromosome band 8p22, a common region of allelic loss in multiple human cancers. Genomics. 24: 317-23. PMID 7698754 DOI: 10.1006/Geno.1994.1622 |
0.395 |
|
| 1993 |
Grimes R, Reddy SV, Leach RJ, Scarcez T, Roodman GD, Sakaguchi AY, Lalley PA, Windle JJ. Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9. Genomics. 15: 421-2. PMID 8449511 DOI: 10.1006/Geno.1993.1079 |
0.341 |
|
| 1993 |
Drayna D, Leach RJ, Wood S, Wood S, Othmane KB, Bergerheim U, Blanton SH, Bookstein R, Clarke RA, Daiger SP, Donis-Keller H, Drayna D, Kumar S, Leach RJ, Lüdecke HJ, et al. First international workshop on human chromosome 8 mapping 1993 Cytogenetic and Genome Research. 64: 133-146. DOI: 10.1159/000133571 |
0.304 |
|
| 1991 |
Johnson TL, Sakaguchi AY, Lalley PA, Leach RJ. Chromosomal assignment in mouse of matrix Gla protein and bone Gla protein genes. Genomics. 11: 770-772. PMID 1774075 DOI: 10.1016/0888-7543(91)90089-W |
0.345 |
|
| Show low-probability matches. |